173 related articles for article (PubMed ID: 36282188)
1. Systemic circulating microRNA landscape in Lynch syndrome.
Sievänen T; Korhonen TM; Jokela T; Ahtiainen M; Lahtinen L; Kuopio T; Lepistö A; Sillanpää E; Mecklin JP; Seppälä TT; Laakkonen EK
Int J Cancer; 2023 Mar; 152(5):932-944. PubMed ID: 36282188
[TBL] [Abstract][Full Text] [Related]
2. Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome.
Canet-Hermida J; Marín F; Dorca E; Dueñas N; Costas L; Salinas M; Velasco À; Peremiquel-Trillas P; Paytubi S; Ponce J; Fernández S; Martínez JM; Cárdenas L; Taltavull A; Alemany L; Meléndez C; Oliveras G; Vidal A; Capellá G; López-Bonet E; Brunet J; Matias-Guiu X; Pineda M
Mod Pathol; 2023 Jul; 36(7):100158. PubMed ID: 36918055
[TBL] [Abstract][Full Text] [Related]
3. Targeted gene sequencing of Lynch syndrome-related and sporadic endometrial carcinomas.
Libera L; Craparotta I; Sahnane N; Chiaravalli AM; Mannarino L; Cerutti R; Riva C; Marchini S; Furlan D
Hum Pathol; 2018 Nov; 81():235-244. PubMed ID: 30420047
[TBL] [Abstract][Full Text] [Related]
4. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
5. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.
Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ
Front Immunol; 2019; 10():3023. PubMed ID: 31998307
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
7. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
8. Targeted next-generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families.
Talseth-Palmer BA; Bauer DC; Sjursen W; Evans TJ; McPhillips M; Proietto A; Otton G; Spigelman AD; Scott RJ
Cancer Med; 2016 May; 5(5):929-41. PubMed ID: 26811195
[TBL] [Abstract][Full Text] [Related]
9. Strategies for Lynch syndrome identification in selected and unselected gynecological cancers.
Carnevali I; Sahnane N; Chiaravalli AM; Di Lauro E; Facco C; Facchi S; Casarin J; Ghezzi F; Sessa F; Tibiletti MG
Eur J Cancer Prev; 2022 Jul; 31(4):369-376. PubMed ID: 34519692
[TBL] [Abstract][Full Text] [Related]
10. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
11. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
[TBL] [Abstract][Full Text] [Related]
12. Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases.
Lotsari JE; Gylling A; Abdel-Rahman WM; Nieminen TT; Aittomäki K; Friman M; Pitkänen R; Aarnio M; Järvinen HJ; Mecklin JP; Kuopio T; Peltomäki P
Breast Cancer Res; 2012 Jun; 14(3):R90. PubMed ID: 22691310
[TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
14. DNA mismatch repair-deficient non-neoplastic endometrial glands are common in Lynch syndrome patients and are present at a higher density than in the colon.
Hegazy S; Brand RE; Dudley B; Karloski E; Bhargava R; Elishaev E; Pai RK
Histopathology; 2021 Oct; 79(4):573-583. PubMed ID: 33847404
[TBL] [Abstract][Full Text] [Related]
15. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer.
Li Y; Fan L; Zheng J; Nie X; Sun Y; Feng Q; Lian S; Bai W; Cai W; Yang Y; Su B; Xi Y; Lin D
Cancer Biol Med; 2022 Jun; 19(8):1235-48. PubMed ID: 35638907
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors.
Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM
Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238
[TBL] [Abstract][Full Text] [Related]
17. Somatic mismatch repair testing in evaluation of Lynch syndrome: The gap between preferred and current practices.
Williams D; Vilar E; Shakrukh Hashmi S; Choates M; Noblin S; Mork M
J Genet Couns; 2020 Oct; 29(5):728-736. PubMed ID: 31896172
[TBL] [Abstract][Full Text] [Related]
18. [A family with clustered Lynch syndrome: a case report].
Zhu X; Cai L; Xiao J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1263-1266. PubMed ID: 36073228
[TBL] [Abstract][Full Text] [Related]
19. An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach.
Dondi G; Coluccelli S; De Leo A; Ferrari S; Gruppioni E; Bovicelli A; Godino L; Coadă CA; Morganti AG; Giordano A; Santini D; Ceccarelli C; Turchetti D; De Iaco P; Perrone AM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003368
[TBL] [Abstract][Full Text] [Related]
20. Molecular changes preceding endometrial and ovarian cancer: a study of consecutive endometrial specimens from Lynch syndrome surveillance.
Niskakoski A; Pasanen A; Lassus H; Renkonen-Sinisalo L; Kaur S; Mecklin JP; Bützow R; Peltomäki P
Mod Pathol; 2018 Aug; 31(8):1291-1301. PubMed ID: 29588532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]